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Reliability of measurements with Innocor during exercise
Abstract
Cardiac output represents the primary determinant of cardiovascular function. Therefore, understanding
how cardiac output is regulated during exercise is crucial. A recently developed tool for determining
cardiac output is the Innocor rebreathing system, which also incorporates an ergospirometry unit. So far,
Innocor's test-retest reliability under exercise conditions has not been determined in healthy participants.
Therefore, 15 male and 15 female healthy participants [30.6 y (SD 4.5); 68.0 kg (SD 10.5)] performed 2
test sessions, each consisting of 2 graded exercise tests to volitional exhaustion. We determined intra-
and inter-session reliability of cardiac output, oxygen consumption, carbon dioxide output, and
ventilation at 130 W and at peak exercise. For cardiac output, we found averaged coefficients of
variation ranging from 4.3 (intra-session, 130 W) to 10.0% (inter-session, rest). For oxygen
consumption, coefficients of variation ranged from 3.4 (intra-session, peak) to 5.7% (inter-session,
peak). Coefficients of variation for carbon dioxide output were between 4.4 (intra-session, peak) and
6.6% (inter-session, peak), and for ventilation between 5.1 (intra-session, 130 W) and 7.0%
(intra-session, peak). Innocor delivers safe and reliable measurements of cardiac output, gas exchange,
and ventilation. Therefore, Innocor can be used to assess these parameters in exercise physiology studies
as well as in performance diagnostics.
 1 
Reliability of measurements with Innocor™ during exercise 
 2 
ABSTRACT 
Cardiac output represents the primary determinant of cardiovascular function. Therefore, 
understanding how cardiac output is regulated during exercise is crucial. A recently 
developed tool for determining cardiac output is the Innocor™ rebreathing-system, which 
also incorporates an ergospirometry unit. So far Innocor™’s test-retest reliability under 
exercise conditions has not been determined in healthy subjects. Therefore, 15 male and 15 
female healthy subjects [30.6 y (SD 4.5); 68.0 kg (SD 10.5)] performed 2 test sessions, each 
consisting of 2 graded exercise tests to volitional exhaustion. We determined intra- and inter-
session reliability of cardiac output, oxygen consumption, carbon dioxide output, and 
ventilation at 130 W and at peak exercise. For cardiac output, we found averaged coefficients 
of variation ranging from 4.3 (intra-session, 130 W) to 10.0% (inter-session, rest). For 
oxygen consumption, coefficients of variation ranged from 3.4 (intra-session, peak) to 5.7% 
(inter-session, peak). Coefficients of variation for carbon dioxide output were between 4.4 
(intra-session, peak) and 6.6% (inter-session, peak), and for ventilation between 5.1 (intra-
session, 130 W) and 7.0% (intra-session, peak). Innocor™ delivers safe and reliable 
measurements of cardiac output, gas exchange, and ventilation. Therefore, Innocor™ can be 
used to assess these parameters in exercise physiology studies as well as in performance 
diagnostics. 
 




Maximal oxygen consumption is an important correlate of endurance performance and 
constitutes a measure of cardiorespiratory capacity. However, the primary distinguishing 
characteristic of elite endurance athletes is a high cardiac output from a large, compliant heart 
generating a large stroke volume [18]. Thus, understanding how cardiac output is regulated 
during acute exercise and consequently, how it can be effectively trained, is of crucial 
importance for sports and rehabilitation. So far, investigations into the dynamics of cardiac 
output and stroke volume during maximal exercise have been hampered by the highly 
invasive nature of the standard techniques used for measuring cardiac output. In this regard, 
the current gold standard technique for measuring cardiac output is the direct Fick method 
[11], which uses cardiac catheterisation. Furthermore, dye- and thermodilution techniques 
[10, 19], both employing central venous catheterisation, are standardly used by cardiologists 
as well as in exercise physiology studies. 
To overcome the problems associated with invasive approaches, non-invasive techniques 
have been developed over the past decades [e.g. 4, 7, 9, 13, 16, 26, 27]. One promising non-
invasive approach is inert gas rebreathing, which can be performed using different gases (e.g. 
acetylene, carbon dioxide, nitrous oxide) [26, 27]. A commercially available device, which 
offers non-invasive cardiac output measurements by inert gas rebreathing and has the 
potential for broad applications in performance diagnostics, is the Innocor™ system 
(Innovision, Odense, Denmark). In detail, Innocor™ uses an oxygen-enriched mixture of 
0.5% nitrous oxide (blood soluble) and 0.1% sulphur hexafluoride (blood insoluble) and 
analyses gas concentrations with a photoacoustic sensor. In addition to the rebreathing 
component, Innocor™ comprises a breath-by-breath system, which enables the assessment of 
gas exchange and ventilation. While Innocor™’s gas exchange and ventilation measurements 
have not yet been validated against the Douglas bag method (gold standard), validation of the 
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Innocor™ cardiac output measurement against direct Fick showed a good accordance [1, 12, 
21]. Additionally, agreement between Innocor™ and the other invasive techniques (dye- and 
thermodilution methods) was shown to be good, too [1, 8, 12, 24]. However, up to now, there 
are no published data for the test-retest reliability of neither the Innocor™ breath-by-breath 
ergospirometry nor the Innocor™ non-invasive determination of cardiac output at 
submaximal and maximal power during exercise in young, healthy asymptomatic subjects. 
Therefore, we investigated the within- (intra), as well as between- (inter) session reliability of 
the Innocor™ device with respect to cardiac output and breath-by-breath measurements in 
healthy male and female study participants and assessed, whether Innocor™ can be used for 




Following the recommendations of Walter et al. [25] for test-retest reliability studies, we 
recruited 15 men and 15 women by placard. Participants were aged 30.6 y (SD 4.5) and 
weighed 68.0 kg (SD 10.5). Their peak oxygen consumption was 3.20 l·min-1 (SD 0.71) and 
peak power was 268 W (SD 56) [range over all tests: 266 (SD 57) to 272 W (SD 56)]. All 
participants were healthy (asymptomatic), non-smoking, and recreationally active.  In order 
to avoid fatigue-related effects on test performance, we allowed no strenuous physical 
activity for 48 h prior to the measurement sessions. After the completion of a routine health 
questionnaire, we informed the participants about the procedures applied and about the 
associated risks. All participants signed an informed consent. The experimental protocol was 
approved by the ethics committee of the Swiss Federal Institute of Technology (ETH) Zurich. 
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Study design and experimental setup 
All participants performed 2 (subsequently denoted A and B) cycle ergometer test sessions 
(Ergoselect 200K, Ergoline, Bitz, Germany), which took place 7 d apart. Both, sessions A 
and B, consisted of 2 graded exercise tests (A1 and A2; B1 and B2) with 1 h rest in between. 
At the beginning of session A, we informed the participants about the upcoming procedures. 
Then, we equipped them with a facemask (Hans Rudolph, Shawnee, KS, USA), an anti-
bacterial filter (PALL PRO1087, Pall, East Hills, NY, USA), and the arterial oxygen 
saturation sensor (Innocor™, Innovision, Odense, Denmark). After that, all participants 
practiced the rebreathing technique with ambient air while sitting on the ergometer (3 
attempts, only during the first session), as described by Sobański et al. [24]. Immediately 
after practicing, we measured cardiac output at rest in the same, seated position. 
Subsequently, the participants rested for another 2 min while sitting on the ergometer. After 
that, they started pedalling at either 100 W (males) or 70 W (females) at a freely chosen 
pedalling rate (≥ 70 min-1), which they then held constant throughout all tests. We determined 
cardiac output at 130 W and right before volitional exhaustion (“peak exercise”). 
Measurements in men and women were performed at the same absolute submaximal power 
instead of at a comparable relative intensity (e.g. 50% of peak oxygen consumption), because 
we aimed at investigating the reliability of the Innocor™ device and not inter-participant 
differences in the physiological parameters. Volitional exhaustion was defined as the point in 
time, at which the participants stopped pedalling or the required pedalling rate could no 
longer be sustained. Throughout the entire test, we continuously measured oxygen 
consumption, carbon dioxide output, ventilation, and arterial oxygen saturation (Innocor™, 
Innovision, Odense, Denmark). Blood lactate concentration was measured at the end of each 
stage, as well as at exhaustion, based on 20 µl of arterialised venous blood taken from an 
earlobe. Blood samples were enzymatically analysed with a BIOSEN C_line Sport® (EKF-
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diagnostic, Barleben, Germany). All measurements were performed by the same investigator. 
The measurements were performed in an automatically ventilated laboratory at a temperature 
of 21°C (SD 1) and a relative humidity of 46% (SD 6). 
Measurement of cardiac output 
We used an Innocor™ inert gas rebreathing unit with breath-by-breath ergospirometry option 
and arterial oxygen saturation sensor (Innovision, Odense, Denmark) for all measurements. 
The closed rebreathing system consisted of a 3-way respiratory valve connecting a facemask, 
an anti-static rubber bag, and an infrared photoacoustic gas analyser [3]. Before each 
rebreathing, the gas mixture was filled into an anaesthesia bag with a volume of 3 to 6 l, 
depending on the individual participant’s predicted vital capacity [22]. As rebreathing gases, 
we used nitrous oxide and sulphur hexafluoride, diluted with oxygen and atmospheric air. We 
set the rebreathing parameters for assessing cardiac output at rest to a total gas mixture 
volume of 40% of the predicted vital capacity [22], to 20% bolus volume, and to a 
rebreathing frequency of 20 min-1. For measuring cardiac output during submaximal and 
maximal exercise, the system calculated the individual rebreathing parameters for each 
participant. As general conditions, we allowed a maximal bolus volume of 40%, a minimal 
oxygen content of 13%, and a maximal carbon dioxide content of 15%. The participants 
performed rebreathing over 5-8 breaths, of which the first 2-3 breaths were excluded from 
calculation due to incomplete gas mixing. The Innocor™ software calculated pulmonary 
blood flow and cardiac output from the rate of uptake of nitrous oxide, taking into account 
estimated shunt flow [12]. The calculation was based on the slope of a regression line 
through the logarithmically transformed alveolar nitrous oxide concentrations plotted against 





At 130 W and at exhaustion, we averaged the breath-by-breath ergospirometry data of 
oxygen consumption, carbon dioxide output, and ventilation over 30 s. With respect to the 
130 W stage, the considered 30 s time period corresponded to the 30 s right before the 
rebreathing started. For peak values, we took the highest 30 s mean value. At 130 W, cardiac 
output was measured during the last 30 s of the 2 min stage. At exhaustion, the rebreathing 
started right before the end of the test. In order to determine the last possible measurement 
point in time before the participants stopped pedalling, we asked them to indicate their last 30 
s before exhaustion by lifting up their right forearm. We defined peak cardiac output as the 
highest value achieved throughout the test. During the rebreathings, arterial oxygen saturation 
was averaged over 30 s. All calculated means and cardiac output values of all participants 
were averaged and then compared. 
Statistical analysis 
We visually checked the data for normality using a Q-Q-plot. Then we examined the data for 
heteroscedasticity using Bland-Altman plots and subsequently performed ANOVA with 
repeated measures and Bonferroni correction on 100Log-transformed values for comparisons 
between A1 and A2, B1 and B2, as well as A1 and B1. Statistical significance was set to P < 
0.05. We then calculated relative as well as absolute intra- (A1 vs. A2, and B1 vs. B2) and 
inter-session (A1 vs. B1) reliability for cardiac output, oxygen consumption, carbon dioxide 
output, and ventilation. According to Atkinson and Nevill [2], relative reliability concerns the 
degree to which individuals maintain their position in a sample with repeated measurements. 
We calculated this type of reliability by means of intraclass correlation coefficient. The 
intraclass correlation coefficient explains the measurement error relative to the total variance. 
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For calculating the intraclass correlation coefficient we used a 2-way random effects model 
with single-measure reliability and variance considered over the repeated session [23]. In 
contrast to relative reliability, absolute reliability indicates the intra-participant variance over 
repeated measurements [2, 14]. We expressed this type of reliability as the coefficient of 
variation and the change in the mean [2, 14]. Coefficient of variation represents the noise of a 
measurement separate from a systematic error. It was calculated as 100·(eSEM/100-1), with 
SEM = standard error of measurement (standard deviation of the difference scores divided by 
€ 
2 ) [14]. The change in the mean consists of 2 components (a random and a systematic 
change). Whereas the random change simply arises from the random error of a measurement, 
the systematic change between trials may indicate a learning effect or may reflect metabolic 
changes due to fatigue between trials [14]. We used SPSS 16.0 statistical software (SPSS, 
Chicago, IL, USA) for all calculations. 
RESULTS 
For all measures and conditions, correlation coefficients of absolute differences vs. individual 
means were positive (Bland-Altman plots), yet close to 0 (Figures 1 to 3). According to 
Atkinson and Nevill [2], this indicates very slight heteroscedasticity. Therefore, we 
performed all analyses on 100Log-transformed data [2, 14]. 
  
Absolute reliability 
Changes in the mean: Mean values of cardiac output, oxygen consumption, and ventilation 
did not significantly differ between the tests at rest, at 130 W, as well as at exhaustion (Table 
1). However, for all measures and all conditions, inter-session changes in the mean tended to 
be higher than intra-session changes in the mean (Table 1). In contrast to cardiac output, 
oxygen consumption, and ventilation, the values of carbon dioxide output at 130 W and at 
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peak exercise were lower in the second tests (A2 and B2) than in the first tests (A1 and B1) 
for both test sessions (A and B) (Table 1). Concomitantly, blood lactate concentrations at 130 
W and at exhaustion tended to be lower during tests A2 and B2 compared to tests A1 and B1, 
but without reaching statistical significance. Inter-session (A1 vs. B1), the mean values of 
carbon dioxide output (130 W and peak exercise) were the same (Table 1). At rest, cardiac 
output was 5.3 l·min-1 (SD 0.9) in A1, 5.4 l·min-1 (SD 0.9) in A2, 5.4 l·min-1 (SD 1.1) in B1, 
and 5.5 l·min-1 (SD 1.2) in B2. Corresponding changes in the mean for intra-session A were 
0.1 l·min-1 (95% confidence interval -0.1−0.3 l·min-1), for intra-session B 0.1 l·min-1 (95% 
confidence interval -0.2−0.3 l·min-1), and for inter-session 0.1 l·min-1 (95% confidence 
interval -0.2−0.3 l·min-1). For 100Log-transformed data, relative changes in the mean were 
1.9% (95% confidence interval -1.6−5.6%, P = 0.840) for session A, 1.7% (95% confidence 
interval -2.7−6.2%, P = 1.000) for session B, and intra-session A and B 0.8% (95% 
confidence interval -4.1−6.0%, P = 1.000). 
Coefficients of variation: The intra-session coefficients of variation for cardiac output 
measurements at rest were 6.9 (95% confidence interval 5.5−9.4%) and 8.6% (95% 
confidence interval 6.8−11.8%) for sessions A and B, respectively.  Between sessions, the 
respective coefficient of variation was 10.0% (95% confidence interval 7.9−13.6%). 
Relative reliability 
Intraclass correlation coefficient: During exercise, intraclass correlation coefficients were 
high for all measures during all conditions (intra-session A and B as well as inter-session) 
(Table 3). At rest, the calculated intraclass correlation coefficients for cardiac output 
measurements were 0.85 (95% confidence interval 0.70−0.92, P < 0.001) (session A) and 
0.82 (95 % confidence interval 0.65−0.91, P < 0.001) (session B). The inter-session intraclass 




This study shows that test-retest reliability for determining cardiac output by means of the 
Innocor™ device is high for measurements at rest, at a submaximal power (130W), and at 
peak exercise (volitional exhaustion) during repeated graded exercise tests (Tables 1, 2, and 
3). Our results further indicate that test-retest reliability for breath-by-breath ergospirometry 
during exercise is high (Tables 1, 2, and 3). To our knowledge, this is the first study 
demonstrating that Innocor™ delivers reliable measurements of cardiac output and breath-by-
breath ergospirometry in healthy humans under exercise conditions. 
Evidence that cardiac output measurements by Innocor™ inert gas rebreathing are reliable is 
that both measures of absolute reliability (coefficients of variation and changes in the mean) 
were low for all conditions (Tables 1 and 2) and intraclass correlation coefficients (relative 
reliability) were high at rest and during exercise (Table 3). Furthermore, in future tests with 
healthy, recreationally active participant, inter-session cardiac output values will differ due to 
a measurement error by maximally ±30% at rest (bias 1%), ±19% at 130 W (bias 2%) and 
±21% at peak exercise (bias 3%), assuming that respective biases are negligible (Figures 1 to 
3) [2]. With respect to intra-session reliability, sessions A and B were similar at rest, during 
submaximal, and maximal exercise (Tables 1, 2, and 3). Since at rest, intra-session reliability 
(coefficient of variation and change in the mean) for session A was slightly higher than for 
session B, it is unlikely that a learning effect occurred in between the sessions. Furthermore, 
the small, yet non-significant changes in the mean concerning cardiac output also under 
exercise conditions might exclude a learning effect over the trials. Therefore, our data imply 
that 3 familiarisation trials with ambient air before the first inert gas rebreathing are sufficient 
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to make the participants familiar with the rebreathing procedure and to ensure a high 
reliability of the cardiac output measurements during all subsequent tests. 
 
We observed that inter-session reliability, in terms of the coefficient of variation and the 
intraclass correlation coefficient, was slightly lower than intra-session reliability (Tables 2 
and 3). We believe that the slightly lower inter-session reliability for cardiac output 
determinations may simply reflect small physiological fluctuations between different days, as 
shown for other physiological parameters such as maximal oxygen consumption and maximal 
power [17]. 
 
Evidence for the high test-retest reliability of Innocor™ breath-by-breath ergospirometry 
during exercise is that we found low coefficients of variation during submaximal, as well as 
at peak exercise (Table 2). With the exception of intra-session carbon dioxide output, changes 
in the mean were small for all measures, too (Table 1). Furthermore, intraclass correlation 
coefficients during submaximal and peak exercise were high (Table 3). As for cardiac output, 
absolute and relative ergospirometry reliabilities within sessions were slightly higher than 
between sessions (except for intraclass correlation coefficients for peak ventilation, which 
were the same for intra-session B and inter-session, and the coefficients of variation for peak 
ventilation, which were slightly higher intra-session B than inter-session). However, the 
small differences between inter-session and intra-session reliability appear to result from the 
physiological fluctuation between days that is pertinent to most ergospirometry variables 
[17]. One variable for which we consistently found lower values in the second test of the 
same test session (A2 vs. A1, and B2 vs. B1) was carbon dioxide output (with blood lactate 
concentrations tending to be lower in A2 and B2 compared to A1 and B1, as well as without 
concurrent changes in oxygen consumption). As a result, respiratory exchange ratios were 
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lower in the second intra-session tests. It has been shown that lower respiratory exchange 
ratio values correlate with glycogen depletion during exercise [15]. Accordingly, we suggest 
that the contribution of carbohydrate oxidation to total energy expenditure probably was 
reduced in the second test of the same test session. Thus, the intra-session changes in the 
mean concerning carbon dioxide output may not primarily reflect a random change, but to a 
larger extent also a systematic bias, which may have been evoked by the experimental 
protocol (2 tests to exhaustion with a 1 h break in-between) and reflects changes in 
carbohydrate and fat metabolism due to depleted glycogen stores. As a consequence, a 
measurement bias based on technical reasons should be excluded. 
 
Practical implications for performance diagnostics and scientific studies: Coaches, 
physicians, scientists, and other professionals using performance tests to monitor mechanical 
and physiological parameters as functions of exercise intensity and/or time must regularly 
decide on whether a “real” change in performance has occurred following e.g. training. 
According to Hopkins [14], a threshold for deciding that in an individual, a real change has 
occurred, appears to be 1.5 to 2.0 times the coefficient of variation. Accordingly, given the 
calculated inter-session coefficient of variation of 7.0% for peak cardiac output 
determinations by Innocor™, real improvements in individual participants would be 
detectable if larger than 9.5 to 14% (holds true for healthy, young participants). Changes 
equal in this magnitude have previously been reported in training studies [5, 6]. Thus, to 
detect changes in Innocor™-derived peak cardiac output in the order of 10% with type 1 and 
2 errors being 5 and 20%, respectively, a scientific, fully controlled training study (training 
vs. control) would need to include 16 participants per group. Therefore, determining cardiac 
output by the Innocor™ system might be precise enough to assess central haemodynamic 
adaptations following training interventions for performance diagnostic purposes as well as in 
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scientific studies employing young, healthy individuals. Accordingly, peak oxygen 
consumption as determined by Innocor™ would have to change in an individual by 8 to 10% 
in order to represent a real change [14]. Since it has been shown in previous studies [5, 6, 20] 
that changes of this magnitude are likely to occur after training periods of 6 to 8 weeks, 
breath-by-breath oxygen consumption measurements by Innocor™ are reliable enough to be 
employed for performance diagnostic purposes. Furthermore, the reliability of Innocor™ 
enables sample sizes of 11 participants per group in fully controlled training studies with the 
aim of detecting significant 10% changes in peak oxygen consumption (type 1 error 5%, type 
2 error 20%). 
 
In summary, we have shown that Innocor™ provides reliable measurements of cardiac output 
and gas exchange in healthy male and female participants at rest and during submaximal and 
peak exercise, both for 2 tests being performed on the same day, and for 2 tests being 
performed on 2 different days. In particular, both measures of absolute reliability (coefficient 
of variation and change in the mean) were low, whereas relative reliability (intraclass 
correlation coefficient) was high. Our data further indicate that measuring cardiac output, gas 
exchange, and ventilation by means of Innocor™ is reliable enough to detect real training-
induced changes in these parameters in healthy young individuals for performance diagnostic 
purposes. We conclude that cardiac output, gas exchange, and ventilation can reliably and 
safely be determined during graded exercise tests by means of Innocor™ and that Innocor™ 
may prove to be a useful tool for performance diagnostic purposes. 
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Table 1 Values of cardiac output, oxygen consumption, carbon dioxide output, and ventilation at 130 W and at exhaustion
A1 A2 A1 - A2 B1 B2 B1 - B2 A1 - B1 A1 A2 A1 - A2 B1 B2 B1 - B2 A1 - B1
Cardiac output (l·min-1) 12.7 (1.7) 12.9 (1.8) p = 0.432 12.9 (1.6) 12.6 (1.5) p = 0.285 p = 0.843 17.0 (3.0) 16.6 (2.5) p = 0.555 16.4 (2.2) 16.7 (2.4) p = 0.435 p = 0.177
Oxygen consumption  (l·min-1) 2.04 (0.20) 2.06 (0.19) p = 0.927 2.05 (0.20) 2.06 (0.20) p = 1.000 p = 1.000 3.18 (0.70) 3.17 (0.72) p = 1.000 3.24 (0.75) 3.23 (0.70) p = 1.000 p = 0.756
Carbon dioxide output  (l·min-1) 1.74 (0.17) 1.68 (0.16) p = 0.030 1.77 (0.20) 1.68 (0.16) p < 0.001 p = 0.840 3.43 (0.65) 3.29 (0.67) p < 0.001 3.49 (0.77) 3.35 (0.67) p = 0.015 p = 1.000
Ventilation  (l·min-1) 47 (6) 47 (6) p = 1.000 48 (7) 47 (8) p = 1.000 p = 1.000 106 (20) 103 (21) p = 0.186 102 (22) 101 (21) p = 1.000 p = 0.083
-0.6 (-4.1 to 3.0) -4.2 (-7.3 to -0.9)
-1 (-4 to 3) -4 (-8 to 0)
b
2.1 (-0.7 to 5.0) -1.9 (-4.0 to 0.3) 1.8 (-0.7 to 4.4)
-3.2 (-5.5 to -0.8) -4.9 (-7.1 to -2.7)
0.3 (-2.4 to 3.1)
-0.14 (-0.24 to -0.04)
0.9 (-0.9 to 2.8)
b 1.4 (-1.7 to 4.5) -3.2 (-6.0 to -0.3)0.1 (-2.7 to 3.0) -0.9 (-3.5 to 1.7)
1.8 (-1.5 to 5.1) -4.4 (-6.5 to -2.2) 1.1 (-2.2 to 4.6)-3.6 (-6.0 to -1.2)
-0.01 (-0.08 to 0.06)
-0.1 (-1.8 to 1.7)
-0.4 (-1.0 to 0.1)
1.7 (-1.2 to 4.7)
-0.7 (-1.3 to 0.0)
0.06 (-0.03 to 0.15)
0.06 (-0.06 to 0.18)
-0.4 (-2.2 to 1.4)
-3.4 (-6.8 to 0.1)
0.2 (-0.2 to 0.6)
0.01 (-0.05 to 0.06) -0.01 (-0.07 to 0.05)
0.03 (-0.02 to 0.09)
1 (-1 to 2) -3 (-6 to 0)
-0.14 (-0.22 to -0.07)
b 0.4 (-1.8 to 2.7)





b 1.8 (-1.5 to 5.2) -2.1 (-5.2 to 1.1)
Values of cardiac output, oxygen consumption, carbon dioxide output, and ventilation are means and (SD) for 30 subjects (15 male and 15 female). A, intra-session A; B, intra-session B; A1 - B1, inter-session between sessions A and B; p, p-value; a, change in the mean (95% confidence interval); b, change 
in the mean (%) of 100Log data (95% confidence interval).
0.3 (-0.1 to 0.6)
0.02 (-0.02 to 0.06)
-0.05 (-0.09 to -0.02)
0 (-1 to 1)
-0.3 (-0.5 to 0.0)
0.01 (-0.04 to 0.05)
-0.09 (-0.13 to -0.05)
0 (-2 to 1)
0.3 (-0.1 to 0.8)
A B A - B A B A - B
Cardiac output 5.5 4.3 6.4 6.3 4.8 7.0
(4.4 to 7.5) (3.4 to 5.8) (5.1 to 8.7) (5.0 to 8.6) (3.8 to 6.6) (5.5 to 9.5)
Oxygen consumption 3.5 4.3 5.3 3.5 3.4 5.7
(2.8 to 4.7) (3.4 to 5.8) (4.2 to 7.2) (2.8 to 4.8) (2.7 to 4.6) (4.5 to 7.8)
Carbon dioxide output 4.6 4.5 6.4 4.4 4.9 6.6
(3.7 to 6.3) (3.5 to 6.1) (5.0 to 8.7) (3.5 to 6.0) (3.9 to 6.6) (5.2 to 8.9)
Ventilation 5.5 5.1 6.1 5.7 7.0 6.5
(4.4 to 7.5) (4.1 to 6.9) (4.8 to 8.2) (4.5 to 7.8) (5.5 to 9.5) (5.1 to 8.8)
130 W Peak exercise
Table 2 Coefficients of variation of cardiac output, oxygen consumption, carbon dioxide output, and ventilation measurements 
at 130 W and at exhaustion (after 100Log-transformation)
Data in parentheses are 95% confidence intervals. A, intra-session A; B, intra-session B; A - B, inter-session between sessions 
A and B.
Table 3 Intraclass correlation coefficients and corresponding p-values of cardiac output, oxygen consumption, carbon dioxide output, and ventilation measurements at 130 W and at exhaustion (after 100Log-transformation)
Cardiac output 0.84 (0.69 to 0.92) 0.88 (0.76 to 0.94) 0.76 (0.56 to 0.88) 0.86 (0.73 to 0.93) 0.90 (0.79 to 0.95) 0.82 (0.65 to 0.91)
Oxygen consumption 0.88 (0.75 to 0.94) 0.82 (0.65 to 0.91) 0.73 (0.50 to 0.86) 0.98 (0.95 to 0.99) 0.98 (0.96 to 0.99) 0.94 (0.88 to 0.97)
Carbon dioxide output 0.78 (0.59 to 0.90) 0.82 (0.65 to 0.91) 0.65 (0.37 to 0.82) 0.96 (0.91 to 0.98) 0.95 (0.90 to 0.98) 0.91 (0.82 to 0.96)
Ventilation 0.84 (0.69 to 0.92) 0.90 (0.81 to 0.95) 0.83 (0.68 to 0.92) 0.93 (0.85 to 0.96) 0.91 (0.81 to 0.96) 0.91 (0.82 to 0.96)
Data in parentheses are 95% confidence intervals. A, intra-session A; B, intra-session B; A - B, inter-session between sessions A and B; p, p-value.
Peak exercise130 W
A B A - B A B A - B
p < 0.001 p < 0.001 p < 0.001 p < 0.001 p < 0.001 p < 0.001
p < 0.001 p < 0.001 p < 0.001 p < 0.001 p < 0.001 p < 0.001
p < 0.001 p < 0.001 p < 0.001 p < 0.001 p < 0.001 p < 0.001
p < 0.001 p < 0.001 p < 0.001 p < 0.001 p < 0.001 p < 0.001
Figure 1 Bland-Altman plot of 100Log-transformed inter-session cardiac output 
values at rest. Correlation coefficient of absolute difference score vs. mean values 
changed after 100Log-transformation from r=0.00 to r=0.27. Displayed 95% limits of 
agreement are -0.0017±0.0572. A1, cardiac output during the first test of test session 
A; B1, cardiac output during the first test of test session B. 
 
Figure 2 Bland-Altman plot of 100Log-transformed inter-session cardiac output 
values at 130W. Correlation coefficient of absolute difference score vs. mean values 
changed after 100Log-transformation from r=0.17 to r=0.01. Displayed 95% limits of 
agreement are -0.0038±0.0375. A1, cardiac output during the first test of test session 
A; B1, cardiac output during the first test of test session B. 
 
Figure 3 Bland-Altman plot of 100Log-transformed inter-session peak cardiac output 
values. Correlation coefficient of absolute difference score vs. mean values changed 
after 100Log-transformation from r=0.39 to r=0.12. Displayed 95% limits of 
agreement are -0.0074±0.0407. A1, cardiac output during the first test of test session 
A; B1, cardiac output during the first test of test session B. 
 
 
